277 related articles for article (PubMed ID: 1339417)
1. Comparative sequence analyses of Epstein-Barr virus nuclear antigen-2 and -3B genes of a fresh Epstein-Barr virus-2 isolate.
Inoue N; Kikuta H; Yanagi K
Intervirology; 1992; 33(4):180-6. PubMed ID: 1339417
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
Sample J; Young L; Martin B; Chatman T; Kieff E; Rickinson A; Kieff E
J Virol; 1990 Sep; 64(9):4084-92. PubMed ID: 2166806
[TBL] [Abstract][Full Text] [Related]
3. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
Ling PD; Ryon JJ; Hayward SD
J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484
[TBL] [Abstract][Full Text] [Related]
4. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
Jiang H; Cho YG; Wang F
J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
Allday MJ; MacGillivray AJ
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
[TBL] [Abstract][Full Text] [Related]
6. Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen.
Hennessy K; Heller M; van Santen V; Kieff E
Science; 1983 Jun; 220(4604):1396-8. PubMed ID: 6304878
[TBL] [Abstract][Full Text] [Related]
7. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
8. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
9. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection.
Buisson M; Morand P; Genoulaz O; Bourgeat MJ; Micoud M; Seigneurin JM
J Gen Virol; 1994 Feb; 75 ( Pt 2)():431-7. PubMed ID: 8113767
[TBL] [Abstract][Full Text] [Related]
10. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
11. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1.
Ambinder RF; Mullen MA; Chang YN; Hayward GS; Hayward SD
J Virol; 1991 Mar; 65(3):1466-78. PubMed ID: 1847464
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.
Walling DM; Perkins AG; Webster-Cyriaque J; Resnick L; Raab-Traub N
J Virol; 1994 Dec; 68(12):7918-26. PubMed ID: 7966582
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites.
Jones CH; Hayward SD; Rawlins DR
J Virol; 1989 Jan; 63(1):101-10. PubMed ID: 2535719
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen type 1 binding: electron microscopy.
Hirsch I; Reischig J; Benada O; Bartsch D; Brichácek B; Boguszaková L; Vonka V
J Virol Methods; 1988 Dec; 22(2-3):133-42. PubMed ID: 2851598
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Cohen JI; Wang F; Mannick J; Kieff E
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.
Szigeti R; Kallin B; Dillner J; Henle G; Henle W; Lerner RA; Rymo L; Timar L; Klein G
Clin Immunol Immunopathol; 1989 Jun; 51(3):396-405. PubMed ID: 2470542
[TBL] [Abstract][Full Text] [Related]
19. A strategy for precision of genotyping of Epstein-Barr virus by polymerase chain reaction: application for studying Hodgkin's lymphoma.
Lin JC; Lin SC; Mar EC
Leuk Lymphoma; 1994 Nov; 15(5-6):389-97. PubMed ID: 7873996
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.
Aitken C; Sengupta SK; Aedes C; Moss DJ; Sculley TB
J Gen Virol; 1994 Jan; 75 ( Pt 1)():95-100. PubMed ID: 8113744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]